Table 1

List of study cases, their corresponding FNA and tissue diagnoses, the results of c-myc amplification measured by comparative PCR, and G-actin, p53, and DNA abnormality detected by QFIA

Case no.AgeFNA diagnosisTissue diagnosisStagec-myc amplificationAbnormalityComment
G-actinp53DNA
141BenignNaNN
234BenignFAPPNAPOC MET
347BenignNNNAPOC MET
465BenignNNN
560BenignNN
626Benign+NN
742BenignNPN
825BenignFANNN
952BenignNN
10Benign
1123BenignNNN
12Benign
1331Benign++NNN
1444BenignFANNN
1547BenignNNN
1646BenignPNNAPOC MET
1732Benign+++NNN
1840BenignNNN
1929BenignNNN
2030BenignNNP
21Benign+/−
22Benign
2362BenignFCNNN
2461BenignDH+NNP
2536PBDAPNN
2647PBDAFANPN
27PBDA+
2835PBDASA+DH++PNP
2948PBDANNN
3034PBDAFC+NPNAPOC MET
3129PBDANNN
3262PBDADCIS+PNN
3360PBDAFCNNN
3451PBDAFA+FCNNN
3545PBDASA+DHPNNAPOC MET
3646PBDA+NNN
3738CAIDC, PD+PNP
3878CAT3+PNN
3951CAT3+++UnsatUnsatUnsat
4060CAT3++PNP
4141CAIDC, WDT2N1+NPP
4250CAIP+DCIS++PPP
4383CAIDC, MD++PNP
4448CAIDC, HG+PPN
4543CAIDC/ILC, PDT2N1+PPP
46CAT3
4738CAIDC, PDT1N1+PPP
4871CAIP+ DCIS+PNN
49CAT3+
5043CAIDC, WDT2N1+PNP
5171CAIDC, MDT1N0+PNP
5268CAIDC, MDT2N1+PNP
5338CAIDC, HGT2N1++PNP
  • a N, negative; P, positive; FC, fibrocystic change; FA, fibroadenoma; DH, ductal hyperplasia of usual type; SA, sclerosing adenosis; IDC, infiltrating ductal carcinoma; ILC, infiltrating lobular carcinoma; IP, intraductal papilloma; DCIS, ductal carcinoma in situ; PD/MD/WD, poor/moderate/well differentiation; Unsat, unsatisfactory due to too few cells measured.